ADAM9 mRNA expression was higher in GBM patient samples (8.139 ± 4.922 transcripts per million, TPM, units) as compared to LGG patients (4.098 ± 2.132 TPM units), and this difference was significant (p < 0.001, t-test, Figure 1). Here, ADAM9 is linked to glioblastoma.